In this article, we discuss the top 10 stock picks of Joshua Kushner’s Thrive Capital. You can skip our comprehensive analysis of Thrive Capital’s history, investment philosophy, and hedge fund performance, and go directly to Top 5 Stock Picks of Joshua Kushner’s Thrive Capital.

Joshua Kushner, an American billionaire businessman and investor, founded Thrive Capital in 2009. Thrive Capital is a venture capital business that invests in firms in the field of software, internet, and technology-enabled sectors, with a Q1 portfolio worth about $1.68 billion. Since its founding, Thrive Capital has raised from institutional investors, including Princeton University, Wellcome Trust, and Hall Capital.

New exits from Thrive Capital’s portfolio have been successful. Lemonade, Inc. (NYSE:LMND), an insurance technology company, and Affirm Holdings, Inc. (NASDAQ:AFRM), a financial startup, both went public recently. Thrive Capital also started investing in Opendoor Technologies Inc. (NASDAQ:OPEN) and Compass, Inc. (NYSE:COMP), two businesses that specialize in real estate technology. In September 2020, Thrive Capital led the $185 million Series D round of Airtable, a collaborative cloud software platform. The Series D round valued Airtable at $2.5 billion. Thrive Capital also played a significant role as an investor in the 2017 Series C round of Robinhood Financial (NASDAQ:HOOD).

In February 2022, with almost $3 billion in funding commitments, Thrive Capital completed its eighth fund, with $500 million of that amount set aside for investments in early-stage start-up firms and the remaining $2.5 billion reserved for later-stage businesses. As per 13F filings for the first quarter of 2022, Thrive Capital holds a total of 11 stocks including, Oscar Health Inc. (NYSE:OSCR), Robinhood Markets, Inc. (NASDAQ:HOOD), and Roblox Corporation (NYSE:RBLX).

Our Methodology

The top 10 stock picks of  Thrive Capital were chosen from its Q1 2022 portfolio. The stake value of each stock in the hedge fund is used to determine the order of the list.

10. Blend Labs Inc. (NYSE:BLND)

Thrive Capital’s Stake Value: $663,000

Percentage of Thrive Capital’s 13F Portfolio: 0.06%

Number of Hedge Fund Holders: 20

Blend Labs, Inc. (NYSE:BLND) is a cloud-based software platform provider in the United States for financial services firms. It has two business segments: Blend Platform and Title365. White-label products include mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts. Piper Sandler analyst Arvind Ramnani on July 18 reduced the firm’s price target on Blend Labs, Inc. (NYSE:BLND) to $2.50 from $3.50 and maintained a Neutral rating on the stock.

At the end of the first quarter, Insider Monkey’s data show that 20 hedge funds were bullish on Blend Labs, Inc. (NYSE:BLND), up from 16 funds in the last quarter. As of late June, Chase Coleman and Feroz Dewan’s Tiger Global Management LLC is the leading position holder in the company, with 19.7 million shares worth about $112 million.

In addition to Oscar Health, Inc. (NYSE:OSCR), Robinhood Markets, Inc. (NASDAQ:HOOD), and Roblox Corporation (NYSE:RBLX), elite hedge funds are pouring into Blend Labs, Inc. (NYSE:BLND).

9. Roblox Corporation (NYSE:RBLX)

Thrive Capital’s Stake Value: $879,000

Percentage of Thrive Capital’s 13F Portfolio: 0.08%

Number of Hedge Fund Holders: 40

Roblox Corporation (NYSE:RBLX) is a company that creates and runs an online entertainment platform.

Needham analyst Bernie McTernan raised the firm’s price target on Roblox Corporation (NYSE:RBLX) to $45 from $40 on July 14 and maintained a Buy rating on the stock. The analyst cites conversations he had with 17 of the company’s developers, all of whom expressed optimism about Roblox’s monetization environment, advertising opportunities, and UGC marketplace.

According to Insider Monkey’s data, 40 hedge funds were bullish on Roblox Corporation (NYSE:RBLX) at the end of Q1 2022, down from 61 funds in the earlier quarter. Catherine Wood’s ARK Investment Management is the leading shareholder of the company, with 7.4 million shares worth $221 million.

8. Silvergate Capital Corporation (NYSE:SI)

Thrive Capital’s Stake Value: $1,966,000

Percentage of Thrive Capital’s 13F Portfolio: 0.18%

Number of Hedge Fund Holders: 35

Silvergate Capital Corporation (NYSE:SI) serves as a bank holding company for Silvergate Bank, which offers banking products and services to corporate and individual customers in the United States. Deposit products accepted by the company include interest and noninterest bearing demand accounts, money market and savings accounts, and certificates of deposit. Thrive Capital added Silvergate Capital Corporation (NYSE:SI) to its portfolio in the first quarter of 2022 by purchasing 13,056 shares, worth $1.9 million.

Wells Fargo analyst Jared Shaw on July 20 raised the firm’s price target on Silvergate Capital Corporation (NYSE:SI) to $115 from $100 and maintained an Overweight rating on the stock.

Among the hedge funds tracked by Insider Monkey, 35 funds reported long positions in Silvergate Capital Corporation (NYSE:SI) at the end of Q1 2022, down from 37 funds in the preceding quarter. Catherine Wood’s ARK Investment Management held the biggest stake in the company, with 443,211 shares worth $34.7 million.

7. Hims & Hers Health Inc. (NYSE:HIMS)

Thrive Capital’s Stake Value: $17,070,000

Percentage of Thrive Capital’s 13F Portfolio: 1.59%

Number of Hedge Fund Holders: 21

Hims & Hers Health, Inc. (NYSE:HIMS) runs a multi-specialty telehealth platform that connects patients with licensed healthcare providers. Customers can purchase a variety of health and wellness products and services directly from the company via its websites and mobile application. It also offers recurring prescription medication and ongoing care from healthcare providers, as well as over-the-counter drug and device products, cosmetics, and supplement products, with a primary focus on wellness, sexual health and wellness, skincare, and hair care.

On May 26, Piper Sandler analyst Sean Wieland reduced the firm’s price target on Hims & Hers Health, Inc. (NYSE:HIMS) to $6 from $8 and maintained an Overweight rating on the stock. Wieland tells investors in a research note that the company “continues to deliver phenomenal growth,” but it also has a cash-pay direct-to-consumer business that is dependent on digital marketing and the health of the US consumer. The analyst claims that because of high churn and short-term subscription commitments, past performance is not a guarantee of future results.

According to Insider Monkey’s database, 21 hedge funds were bullish on Hims & Hers Health, Inc. (NYSE:HIMS) at the end of March 2022, down from 22 funds in the previous quarter.

6. Compass Inc. (NYSE:COMP)

Thrive Capital’s Stake Value: $57,295,000

Percentage of Thrive Capital’s 13F Portfolio: 5.36%

Number of Hedge Fund Holders: 28

Compass, Inc. (NYSE:COMP) offers real estate brokerage services in the United States. It operates a cloud-based platform that offers an integrated suite of software for customer relationship management, marketing, client service, operations, and other functionality, as well as brokerage and related services in the real estate industry. The company provides mobile apps that allow agents to manage their business from anywhere, as well as designs consumer-grade interfaces and automated workflows for agent-client interactions.

Equities research analysts at Oppenheimer on June 15 reduced Compass, Inc.’s (NYSE:COMP) target price from $9.00 to $8.00. The company currently rates the stock as “Outperform.”

Among the hedge funds tracked by Insider Monkey, 28 funds reported long positions in Compass, Inc. (NYSE:COMP) at the end of Q1 2022. By the end of June, Rob Citrone’s Discovery Capital Management held the biggest stake in the company, with 19.7 million shares worth $155.3 million.

Like Oscar Health Inc. (NYSE:OSCR), Robinhood Markets, Inc. (NASDAQ:HOOD), and Roblox Corporation (NYSE:RBLX), the smart money is focusing into Compass, Inc. (NYSE:COMP).

Click to continue reading and see Top 5 Stock Picks of Joshua Kushner’s Thrive Capital.

Suggested articles:

• Top 10 Marijuana Stocks to Invest In Right Now
• Top 10 Stock Picks of Minerva Advisors
• Top 10 Stock Picks of Rajiv Jain’s GQG Partners

Disclosure: None. Top 10 Stock Picks of Joshua Kushner’s Thrive Capital is originally published on Insider Monkey.